Top

Rheumatology International

Published in:

01-03-2021 | Coronavirus | Correspondence

Proposal of a new nomenclature for the underlying pathogenetic mechanism of severe Coronavirus Disease-19: “Inflammatory Thrombosis with Immune Endotheliitis—ITIE”

Authors: Emre Bilgin, Ali İhsan Ertenli

Published in: Rheumatology International | Issue 3/2021

Excerpt

Dear Editor, …

Li LQ, Huang T, Wang YQ, Wang ZP, Liang Y, Huang TB, Zhang HY, Sun W, Wang Y (2020) COVID-19 patients’ clinical characteristics, discharge rate, and fatality rate of meta-analysis. J Med Virol 92(6):577–583. https://doi.org/10.1002/jmv.25757CrossRefPubMed

Minoia F, Tibaldi J, Muratore V, Gallizzi R, Bracaglia C, Arduini A, Comak E, Vougiouka O, Trauzeddel R, Filocamo G, Micalizzi C, Kasapcopur O, Unsal E, Kitoh T, Tsitsamis E, Kostik MC, Ron R, Pachlopnik J, Maritsi D, Jelusic M, Shenoi S (2020) A multinational study of thrombotic microangiopathy in macrophage activation syndrome: a dreadful condition which is likely underrecognized [abstract]. Arthritis Rheumatol 72(Suppl 4)

Vasquez-Bonilla WO, Orozco R, Argueta V, Sierra M, Zambrano LI, Munoz-Lara F, Lopez-Molina DS, Arteaga-Livias K, Grimes Z, Bryce C, Paniz-Mondolfi A, Rodriguez-Morales AJ (2020) A review of the main histopathological findings in coronavirus disease 2019. Hum Pathol. https://doi.org/10.1016/j.humpath.2020.07.023CrossRefPubMedPubMedCentral

McGonagle D, O’Donnell JS, Sharif K, Emery P, Bridgewood C (2020) Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia. Lancet Rheumatol 2(7):e437–e445. https://doi.org/10.1016/s2665-9913(20)30121-1CrossRefPubMedPubMedCentral

Webb BJ, Peltan ID, Jensen P, Hoda D, Hunter B, Silver A, Starr N, Buckel W, Grisel N, Hummel E, Snow G, Morris D, Stenehjem E, Srivastava R, Brown SM (2020) Clinical criteria for COVID-19-associated hyperinflammatory syndrome: a cohort study. Lancet Rheumatol. https://doi.org/10.1016/s2665-9913(20)30343-xCrossRefPubMedPubMedCentral

Sinha P, Matthay MA, Calfee CS (2020) Is a “Cytokine Storm” relevant to COVID-19? JAMA Intern Med 180(9):1152–1154. https://doi.org/10.1001/jamainternmed.2020.3313CrossRefPubMed

Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, Vanstapel A, Werlein C, Stark H, Tzankov A, Li WW, Li VW, Mentzer SJ, Jonigk D (2020) Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med 383(2):120–128. https://doi.org/10.1056/NEJMoa2015432CrossRefPubMedPubMedCentral

Piazza G, Morrow DA (2020) Diagnosis, management, and pathophysiology of arterial and venous thrombosis in COVID-19. JAMA. https://doi.org/10.1001/jama.2020.23422CrossRefPubMed

Teuwen LA, Geldhof V, Pasut A, Carmeliet P (2020) COVID-19: the vasculature unleashed. Nat Rev Immunol 20(7):389–391. https://doi.org/10.1038/s41577-020-0343-0CrossRefPubMed

10.

Pine AB, Meizlish ML, Goshua G, Chang C-H, Zhang H, Bishai J, Bahel P, Patel A, Gbyli R, Kwan JM, Won CH, Price C, Dela Cruz CS, Halene S, van Dijk D, Hwa J, Lee AI, Chun HJ (2020) Circulating markers of angiogenesis and endotheliopathy in COVID-19. PulmCirc 10(4):2045894020966547. https://doi.org/10.1177/2045894020966547CrossRef

Title: Proposal of a new nomenclature for the underlying pathogenetic mechanism of severe Coronavirus Disease-19: “Inflammatory Thrombosis with Immune Endotheliitis—ITIE”
Authors: Emre Bilgin
Ali İhsan Ertenli
Publication date: 01-03-2021
Publisher: Springer Berlin Heidelberg
Keywords: Coronavirus
Disseminated Intravascular Coagulation
SARS-CoV-2
Acute Respiratory Distress-Syndrome
COVID-19
Thrombosis
Cytokines
Published in: Rheumatology International / Issue 3/2021
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI: https://doi.org/10.1007/s00296-020-04768-1

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Proposal of a new nomenclature for the underlying pathogenetic mechanism of severe Coronavirus Disease-19: “Inflammatory Thrombosis with Immune Endotheliitis—ITIE”

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 3/2021

Effect of add-on methotrexate in polymyalgia rheumatica patients flaring on glucocorticoids tapering: a retrospective study

SARS-CoV-2 vaccines and autoimmune diseases amidst the COVID-19 crisis

Advances in imaging technologies for the assessment of peripheral neuropathies in rheumatoid arthritis

Colchicine as an adjunct to heparin for prophylaxis of venous thromboembolism in patients with COVID-19

Similar lipid level changes in early rheumatoid arthritis patients following 1-year treat-to-target strategy with adalimumab plus methotrexate versus placebo plus methotrexate: secondary analyses from the randomised controlled OPERA trial

Telemedicine for patients with rheumatic and musculoskeletal diseases during the COVID-19 pandemic; a positive experience in the Netherlands

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page